Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Oct 14, 2011

34519_dirs_2011-10-14_c83a8027-3e71-4af7-8973-d2a966af9d88.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-10-12

Reporting Person: Cunningham David (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-10-12 Non-Qualified Stock Option (Right to Buy) $5.75 A 15000 Acquired 2016-10-11 Common Stock (15000) Direct